Assessment of Dysphonia Using the Japanese Version of the Voice Handicap Index and Determination of Cutoff Points for Screening

Sakaguchi, Yu; Kanazawa, Takemichi; Okui, Ayako; Hirosaki, Mayu; Konomi, Ujimoto; Sotome, Taisuke; Tashiro, Nahoko; Kurihara, Miyuki; Omae, Takumi; Nakayama, Yosuke; Yamamoto, Ai; Sato, Ayane; Misawa, Kiyoshi; Watanabe, Yûsuke

doi:10.1016/j.jvoice.2020.04.031

Cited by 9 publications

(4 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Subjective voice dysfunction was not prominent in the present study, as VHI assessing subjective voice function had very low values as compared to cutoff values reported in previous studies. 23 Second, postoperative objective voice function was not adequately assessed in this study as we used the GRBAS scale, which is not physically invasive or economically burdensome. Although the GRBAS scale ensures measurement reproducibility based on interobserver agreement, acoustic analysis should be incorporated into objective voice function assessment in future studies to allow a more detailed investigation of psychological changes and voice dysfunction.…”

Section: Discussionmentioning

confidence: 99%

Association Between Subjective Voice Assessment and Psychological Distress After Thyroidectomy

Taito

Hamamoto

Chikuie

et al. 2022

Journal of PeriAnesthesia Nursing

View full text Add to dashboard Cite

This study aimed to determine the association between postoperative subjective voice function and psychological distress in patients without laryngeal nerve injury after thyroidectomy. Design: A prospective cohort study. Methods: We investigated the factors associated with subjective voice function in patients who underwent thyroidectomy without laryngeal nerve injury between October 2018 and July 2020. The Voice Handicap Index was used to assess subjective voice function, the GRBAS (grade, roughness, breathiness, asthenia, strain) scale to assess objective voice, and the Hospital Anxiety and Depression Scale to assess psychological distress. Findings: Among 39 patients who underwent thyroidectomy, 32 had no postoperative laryngeal nerve injury. Postoperative Voice Handicap Index was significantly associated with Hospital Anxiety and Depression Scale-Anxiety score after surgery (rs = 0.448, P = .010). Conclusions: In this study, an association was observed between subjective voice function and anxiety following surgery. The finding suggested that nurses and medical practitioners need to consider postoperative anxiety when evaluating patients' voice function after thyroidectomy.

show abstract

Section: Discussionmentioning

confidence: 99%

Association Between Subjective Voice Assessment and Psychological Distress After Thyroidectomy

Taito

Hamamoto

Chikuie

et al. 2022

Journal of PeriAnesthesia Nursing

View full text Add to dashboard Cite

show abstract

“…In this study, vowel utterances were used as stimuli to collect all outcome data. The Japanese version of VHI, 16 which is a subjective voice assessment method, was used as the primary endpoint. Other secondary endpoints included the tGRBAS (the sum of the scores on the tGRBAS scale), maximum phonation time (MPT), mean airflow rate (MFR), pitch range (PR), jitter percentage (jitter%), shimmer percentage (shimmer%), speech fundamental frequency (SFF), noise‐to‐harmonic ratio (NHR), and sound pressure level (SPL).…”

Section: Methodsmentioning

confidence: 99%

Age‐dependent treatment effect of vocal fold steroid injection for benign vocal fold lesions

Nozawa

Kanazawa

Kurakami

et al. 2023

Laryngoscope Investig Oto

Self Cite

View full text Add to dashboard Cite

Objective: Benign vocal fold lesions (BVFLs) cause voice disorders and impair social life. Recently, office-based vocal fold steroid injection (VFSI) has gained attention as a minimally invasive treatment for BVFLs. This study aimed to analyze the agedependent treatment effect of VFSI and to clarify the indications for treatment.Methods: In this retrospective cohort study, a total of 83 patients with BVFLs were treated with a similar regimen of VFSI. Three or four months after the injection, agedependent phonological functions were evaluated. The differences between pre-and post-treatment findings were analyzed using the Wilcoxon matched-pair signed-rank test, and the correlation between patient age and improvement rates were determined by Pearson's correlation coefficient.Results: Improvement in voice handicap index (VHI), which was the primary endpoint, was observed. Subjective and objective voice quality measurements also showed significant improvements. Subgroup analyses revealed that there was no age-related difference in the improvement of voice quality and that there was no improvement in aerodynamic effect in patients over 45 years of age. Conclusion:This study clarified the age-dependent treatment effect of VFSI and provided the important suggestion of establishing indication criteria for BVFLs. The study results provided clarity on the indication criteria of VFSI and served as an important indicator for tailoring treatment to patients' needs.

show abstract

“…Phonological outcomes, maximum phonation time (MPT), mean airflow rate (MFR), pitch range (PR), jitter, shimmer, speech fundamental frequency (SFF), and noise‐to‐harmonic ratio (NHR) were evaluated and the Japanese version of the VHI 27 was administered at 3–6 months after injection. MFR was determined using a Phonatory Function Analyzer (PS‐77E; Nagashima Medical Instruments Company, Ltd.).…”

Section: Methodsmentioning

confidence: 99%

Intracordal injection therapy for vocal fold scarring: Steroid versus basic fibroblast growth factor

Nozawa

Takahashi

Kanazawa

et al. 2022

Laryngoscope Investig Oto

Self Cite

View full text Add to dashboard Cite

Objectives Vocal fold scarring is caused by replacement of vocal fold mucosa with fibrous tissue due to repeated inflammation or trauma. It can lead to severe dysphonia. It is currently treated conservatively and with phonosurgery and intracordal injections. Intracordal injection of steroid or basic fibroblast growth factor (bFGF) has been recently found to be useful for treating vocal fold scarring that does not respond to voice therapy. Methods This retrospective study involved the administration of steroid injection and bFGF injection bilaterally under local anesthesia in 16 patients each. Laboratory measurements of voice parameters were performed before and 3–6 months after injection. Results In the steroid injection group, the Voice Handicap Index (VHI) score significantly improved from 57.1 to 40.5, total Grade, Roughness, Breathiness, Asthenia, Strain (tGRBAS) score significantly improved from 4.2 to 2.6, and mean speech fundamental frequency (SFF) increased from 192.5 to 211.4 dB, but there was no improvement in maximum phonation time (MPT) and mean airflow rate (MFR). In the bFGF injection group, significant improvements in the VHI score (from 53.3 to 35.7), MPT (from 16.9 to 21.8 s) and MFR (from 314.6 to 210.5 ml/s) were seen; however, the tGRBAS score did not improve. In addition, the SFF significantly decreased from 178.1 to 160.5 Hz. Conclusion These results suggest that both steroid and bFGF injections are effective for treating vocal fold scarring, with steroids improving voice quality and bFGF improving glottic closure, thereby contributing to improvements in VHI scores. Level of Evidence 4.

show abstract

Assessment of Dysphonia Using the Japanese Version of the Voice Handicap Index and Determination of Cutoff Points for Screening

Cited by 9 publications

References 23 publications

Association Between Subjective Voice Assessment and Psychological Distress After Thyroidectomy

Association Between Subjective Voice Assessment and Psychological Distress After Thyroidectomy

Age‐dependent treatment effect of vocal fold steroid injection for benign vocal fold lesions

Intracordal injection therapy for vocal fold scarring: Steroid versus basic fibroblast growth factor

Contact Info

Product

Resources

About